First Time Loading...

Epizyme Inc
NASDAQ:EPZM

Watchlist Manager
Epizyme Inc Logo
Epizyme Inc
NASDAQ:EPZM
Watchlist
Price: 1.47 USD
Updated: May 6, 2024

Wall Street
Price Targets

EPZM Price Targets Summary
Epizyme Inc

There are no price targets for EPZM.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available

EPZM Last Price Targets
Epizyme Inc

The latest public price target was made on Jun 3, 2022 by Unknown Analyst from H.C. Wainwright , who expects EPZM stock to rise by 308% over the next 12 months. You can read more about this price target by viewing the article on Benzinga.

Analyst Price Target Date Article
Unknown Analyst
H.C. Wainwright
6 USD
Upside 308%
1 year ago
Jun 3, 2022
HC Wainwright & Co. Maintains Buy on Epizyme, Lowers Price Target to $6
Benzinga
Unknown Analyst
H.C. Wainwright
Price Target 6 USD
Upside/Downside 308%
View Source
Epizyme Inc Competitors:
Price Targets
BCYC
Bicycle Therapeutics PLC
79% Upside
042520
Hans Biomed Corp
175% Upside
HARP
Harpoon Therapeutics Inc
8% Upside
BMRN
Biomarin Pharmaceutical Inc
32% Upside
002038
Beijing SL Pharmaceutical Co Ltd
381% Upside
LGND
Ligand Pharmaceuticals Inc
61% Upside
688687
Beijing Kawin Technology Share-holding Co Ltd
26% Upside
BIOA B
BioArctic AB
88% Upside

Revenue
Forecast

Revenue Estimate
Epizyme Inc

For the last 8 years the compound annual growth rate for Epizyme Inc's revenue is -7%. The projected CAGR for the next 2 years is 57%.

-7%
Past Growth
57%
Estimated Growth
Estimates Accuracy
10%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Epizyme Inc

Operating Income forecast
is not available for
Epizyme Inc

Net Income
Forecast

Net Income Estimate
Epizyme Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-45%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is EPZM's stock price target?
Not Available

EPZM doesn't have any price targets made by Wall Street professionals.

What is Epizyme Inc's Revenue forecast?
Projected CAGR
57%

For the last 8 years the compound annual growth rate for Epizyme Inc's revenue is -7%. The projected CAGR for the next 2 years is 57%.